Hacker News
new
|
past
|
comments
|
ask
|
show
|
jobs
|
submit
login
Mvandenbergh
on May 15, 2020
|
parent
|
context
|
favorite
| on:
Gilead should ditch remdesivir and focus on its si...
Sure but they're both currently under patent protection. Since much of the value of the drug is likely to come in the next 18 months, they're both equally protected.
s1artibartfast
on May 16, 2020
[–]
Why do you assume that? They could be modeling 20 year sales.
BurningFrog
on May 16, 2020
|
parent
|
next
[–]
There will only be a pandemic market for a while.
refurb
on May 16, 2020
|
root
|
parent
|
next
[–]
Sure, but gov'ts will want to stockpile the stuff like Tamiflu. Everyone is going to want to be prepared for the next outbreak.
tjohns
on May 16, 2020
|
parent
|
prev
[–]
Because after 12-18 months, we'll hopefully have a vaccine and won't need to resort to an antiviral drug anymore.
At least assuming people get vaccinated.
briandear
on May 16, 2020
|
root
|
parent
[–]
What’s the rationale for expecting a vaccine in the next 12-18 months? To my knowledge there has never been a vaccine for a coronavirus.
khuey
on May 16, 2020
|
root
|
parent
[–]
There are vaccines for animal coronaviruses. There's never been one in humans because there's never been a need for one in humans before.
Guidelines
|
FAQ
|
Lists
|
API
|
Security
|
Legal
|
Apply to YC
|
Contact
Search: